SK Group chairman Chey Tae-won recently posted photos and videos of San Francisco-based food-tech startup Wildtype making sushi, rolls, and salads with cell-cultivated salmon.
On his Instagram account, Chey said he visited Wildtype during a business trip to the U.S.
According to Chey, Wildtype's technology can significantly reduce carbon dioxide emissions from fishing, fish farming, and transportation, as well as protect the threatened marine ecosystem.
Chey has shown a consistent interest in alternative foods, and spending a significant portion of his time in the US visiting the company and tasting the food suggests that SK may invest in the company.
As part of its ESG investment strategy, SK Inc., the investment and holding company of SK Group, is currently increasing its investments in alternative food companies with core technology.


Extreme heat, flooding, wildfires – Colorado’s formerly incarcerated people on the hazards they faced behind bars
Yes, government influences wages – but not just in the way you might think
Can your cat recognise you by scent? New study shows it’s likely
USMCA Talks Set to Resume as Mexico Signals New Round of Trade Negotiations
Rise of the Zombie Bugs takes readers on a jaw-dropping tour of the parasite world
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed
The Beauty Beneath the Expressway: A Journey from Self to Service
Asian Stocks Rise on AI Optimism and Iran Peace Talk Hopes
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand
NASA Faces Major Workforce Reduction as 20% of Employees Prepare to Leave
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
This fuel crisis could last for a while. It’s time for a new approach to fuel use - end it
Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 



